中国农业科学 ›› 2026, Vol. 59 ›› Issue (10): 2265-2275.doi: 10.3864/j.issn.0578-1752.2026.10.014

• 畜牧·兽医 • 上一篇    下一篇

黏膜层蛋白质糖基化修饰调控畜禽肠道健康的作用机制研究进展

王雨轩(), 顾炯, 夏冰()   

  1. 北京农学院动物科学技术学院/蛋白质高效合成与生物智造北京市重点实验室, 北京 102206
  • 收稿日期:2024-12-25 接受日期:2026-04-09 出版日期:2026-05-16 发布日期:2026-05-20
  • 通信作者:
    夏冰,E-mail:
  • 联系方式: 王雨轩,E-mail:18210388512@163.com。
  • 基金资助:
    国家自然科学基金青年科学基金项目(32302777); 北京农学院科技创新“火花行动”支持计划(BUA-HHXD2023003); 北京市教委科技一般项目(KM202410020005)

Research Progress on the Mechanism of Protein Glycosylation Modification in Regulating Intestinal Health of Livestock and Poultry

WANG YuXuan(), GU Jiong, XIA Bing()   

  1. College of Animal Science and Technology, Beijing University of Agriculture/Beijing Key Laboratory of Efficient Protein Synthesis and Intelligent Biomanufacturing, Beijing 102206
  • Received:2024-12-25 Accepted:2026-04-09 Published:2026-05-16 Online:2026-05-20

摘要:

自2020年我国全面实施饲料“禁抗令”以来,畜禽养殖业面临诸多挑战,包括动物生长发育受阻、饲料转化效率降低及抗病能力下降等。其中,肠道作为机体营养吸收和免疫防御的核心器官,其健康问题日益凸显,表现为肠道屏障受损、炎症反应频发及微生物群落失衡等。畜禽肠道健康对整体生产性能至关重要,而肠道黏膜屏障作为抵御病原体和毒素的第一道防线,通过黏液层、紧密连接、免疫调控及微生物互作等多重机制维持稳态。在这一过程中,蛋白质O-型糖基化修饰扮演关键角色,其通过决定黏蛋白的结构和功能多样性,直接影响屏障完整性。近年来,随着糖组学技术的快速发展,糖基化修饰的复杂结构得以更精准解析,为其在营养干预和疾病防控中的应用奠定基础。本文系统总结了蛋白质糖基化修饰的主要类型及其结构特征,重点阐述了黏蛋白O-糖基化修饰在肠道黏液层中的区域分布差异及功能特性。文章详细分析了唾液酸化、硫酸化和岩藻糖基化三种重要O-糖基化亚型在肠道黏膜屏障中的作用机制:唾液酸化通过增强黏液层负电荷特性,抑制病原菌黏附并调节免疫球蛋白功能;硫酸化修饰提高黏液层稳定性及抗降解能力,并影响微生物识别与定植;岩藻糖基化则通过为共生菌提供碳源及激活免疫轴(如AHR/IL-22)参与宿主防御。此外,本文系统梳理了O-糖基化在调控畜禽免疫应答和微生物互作中的最新研究进展,例如在鸡坏死性肠炎和沙门氏菌感染模型中,O-糖基化异常可导致肠道屏障功能受损,而补充特定单糖(甘露糖、岩藻糖)可通过修复糖链结构缓解炎症。尽管相关研究已取得显著进展,糖基化修饰结构的精准解析及通过营养策略靶向调控关键糖基转移酶(Fut2、St3gal等)仍面临挑战。未来需进一步整合多组学技术、人工智能模型及合成生物学手段,深入揭示糖基化修饰在畜禽肠道疾病发生发展中的分子机制,为实现抗生素禁用后腹泻等问题的精准防控提供新思路,最终助力提升畜禽肠道健康水平和养殖效益。

关键词: 糖基化修饰, 肠道屏障, O-糖基化, 肠道微生物, 免疫反应

Abstract:

Since the implementation of the "antibiotic ban order" for feed in China in 2020, the livestock and poultry breeding industry has faced numerous challenges, including impaired animal growth and development, reduced feed conversion efficiency, and decreased disease resistance. Among these, the intestinal tract, as the core organ for nutrient absorption and immune defense in the body, has increasingly prominent health issues, manifested as damaged intestinal barriers, frequent inflammatory responses, and imbalances in microbial communities. The health of the intestinal tract is crucial for overall production performance, and the intestinal mucosal barrier, as the first line of defense against pathogens and toxins, maintains homeostasis through multiple mechanisms, such as mucus layer, tight junctions, immune regulation, and microbial interactions. In this process, protein O-glycosylation modification plays a key role, as it determines the structural and functional diversity of mucin proteins and directly affects barrier integrity. In recent years, with the rapid development of glycomics technology, the complex structure of glycosylation modifications can be more accurately analyzed, laying the foundation for its application in nutritional intervention and disease prevention. This article systematically summarized the main types of protein glycosylation modifications and their structural characteristics, and focused on the regional distribution differences and functional characteristics of mucin O-glycosylation modifications in the intestinal mucus layer. The article thoroughly analyzed the mechanisms of action of three important O-glycosylation subtypes (sialylation, sulfation, and fucosylation) in the intestinal mucosal barrier: Sialylation enhanced the negative charge of the mucus layer, inhibited pathogen adhesion, and regulated the function of immunoglobulins; Sulfation modification improved the stability and anti-degradation ability of the mucus layer and affected microbial recognition and colonization; Fucosylation provided carbon sources for symbiotic bacteria and activates immune axes (such as AHR/IL-22) to participate in host defense. In addition, this article systematically reviewed the latest research progress of O-glycosylation in regulating the immune response and microbial interactions in livestock and poultry, such as in models of necrotic enteritis and Salmonella infection, O-glycosylation abnormalities could lead to impaired intestinal barrier function, and supplementing specific monosaccharides (mannose, and fucosamine) could alleviate inflammation by repairing the glycan chain structure. Although significant progress has been made in related research, the precise analysis of the glycosylation modification structure and the targeted regulation of key glycosyltransferases (Fut2, St3gal, etc.) through nutritional strategies still face challenges. In the future, it is necessary to further integrate multi-omics technologies, artificial intelligence models, and synthetic biology approaches to deeply reveal the molecular mechanism of glycosylation modification in the occurrence and development of intestinal diseases in livestock and poultry, providing new ideas for the precise prevention and control of issues, such as diarrhea after antibiotic ban, and ultimately helping to improve the intestinal health level and breeding efficiency of livestock.

Key words: protein glycosylation, intestinal barrier, O-glycosylation, gut microbiota, immune response